USANA Health Sciences (USNA) Misses Q2 EPS by 17c; Lowers Outlook, $100M Buyback
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
USANA Health Sciences Reports Second Quarter Financial Results
July 25, 2017 4:17 PM EDTSecond quarter net sales were $257.1 million, a decrease of 0.6% year-over-year, but up 2.3% in constant currency Number of active Customers1 at quarter end increased 1.8% to 567,000 Second quarter EPS of $0.93, or $0.98 excluding incremental expense related to the Companys internal investigation of its China operations disclosed in February 2017 Company revises 2017 Outlook Share repurchase authorization increased to $100 million
SALT LAKE CITY--(BUSINESS WIRE)-- USANA Health Sciences, Inc. (NYSE: USNA) today announced financial... More
